Korede Abdullah 
LAGOS, Nigeria – A new comprehensive review published on Monday in the British Medical Journal (BMJ) has found no clear evidence linking the use of paracetamol during pregnancy with autism or Attention Deficit Hyperactivity Disorder (ADHD) in children.
The UK-led research team analysed all currently available scientific studies and reported that findings remain inconsistent and inconclusive.
“Existing evidence does not show a clear link between in utero exposure to paracetamol and autism and ADHD,” the authors stated.
The publication comes amid renewed public debates over medication safety in pregnancy.
The conclusion aligns with a recent statement by the World Health Organisation (WHO) confirming that there is “no conclusive scientific evidence” connecting the common pain reliever to autism. The WHO issued the clarification after former U.S. President Donald Trump made unsubstantiated claims suggesting a link between childhood vaccines, paracetamol use in pregnancy, and autism — claims global health experts have repeatedly refuted.
“Extensive research over the past decade has not found a consistent association,” the WHO reiterated.
Health authorities, however, advise that medication during pregnancy should be taken with professional guidance.
“WHO recommends that all women follow the advice of their doctors or health workers,” the organisation noted. “Any medicine should be used with caution during pregnancy, especially in the first trimester.”
Medical experts say the review offers reassurance to pregnant women who rely on paracetamol to manage pain and fever — conditions that, if untreated, may pose greater risk to mother and child.
About the Author
Oluwatobi Adu 
Edino Chubiyo Cornelius 
Koko Maxwella 